Alimera Sciences To Present At The 19th Annual Rodman & Renshaw Global Investment Conference

ATLANTA, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth, President and Chief Financial Officer, will present at the 19 th Annual Rodman & Renshaw Global Investment Conference to be held September 10-12, 2017 at the Lotte New York Palace Hotel, New York, New York. Alimera Sciences' presentation will take place Tuesday, September 12 th, 2017 at 3:00pm Eastern Time.

A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Relations" section of the Company's website at  www.alimerasciences.com. A replay of the conference presentation will also be available.

About Alimera Sciences, Inc.

www.alimerasciences.com

Alimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in Alimera's product and development portfolio designed to treat early-and late-stage diseases. For more information, please visit  www.alimerasciences.com.
For press inquiries:Katie Brazelfor Alimera Sciences 404-317-8361kbrazel@bellsouth.netFor investor inquiries:CG Capitalfor Alimera Sciences877-889-1972investorrelations@cg.capital 

Primary Logo